comparemela.com
  1. Home
  2. Live Updates
  3. Manuel Roqueta Rivera - Breaking News

Latest Breaking News On - Manuel roqueta rivera - Page 1 : comparemela.com

Enanta Pharmaceuticals Announces Data Presentation at the European Association for the Study of the Liver (EASL) International Liver Congress 2023

07.06.2023 - Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that preclinical data from Enanta’s out-licensing portfolio has been accepted for a .

Lang schwarzManuel roqueta riveraInternational liver congressEnanta pharmaceuticals incEnanta pharmaceuticals stockPoster titleMouse modelAbstract identifierEnanta pharmaceuticals

Enanta Pharmaceuticals, Inc : Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress 2022

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta's

United kingdomCity ofWalaa ahmadJennifer vieraManuel roqueta riveraFung yuenEnanta pharmaceuticals incDevelopment programsInternational liver congressEnanta pharmaceuticalsEuropean associationNovel pangenotypic classFinal resultsDay phaseViral hepatitisJordan feld

Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the

WATERTOWN, Mass. (BUSINESS WIRE) Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta’s internal development program portfolio for hepatitis B virus (HBV) and its.

United kingdomCity ofWalaa ahmadManuel roqueta riveraFung yuenEnanta pharmaceuticals incDevelopment programsInternational liver congressEnanta pharmaceuticalsEuropean associationNovel pangenotypic classFinal resultsDay phaseViral hepatitisJordan feldPotent pangenotypic class

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.